Acute Myocarditis and Eculizumab Caused Severe Cholestasis in a 17-Month-Old Child Who Has Hemolytic Uremic Syndrome Associated with Shiga Toxin-Producing Escherichia coli

Yeşilbaş, Osman; Akıncı, Nurver; Sonmez, S E; Tekin, Eser; Talebazadeh, Faraz; Jafarov, Uzeyir; Temur, Hafize Otcu; Yozgat, Yılmaz

doi:10.1055/s-0040-1713111

Cited by 6 publications

(1 citation statement)

References 16 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Few reports have discussed the characteristics of coagulation and fibrinolysis markers in STEC-HUS [151][152][153]. PT and APTT are normal to mildly prolonged, fibrinogen is within the normal range, FDP and D-dimer are elevated, and TAT, a marker of coagulation activation, presents as elevated.…”

Section: Stec-husmentioning

confidence: 99%

How We Interpret Thrombosis with Thrombocytopenia Syndrome?

Yamada,

Asakura

2024

IJMS

View full text Add to dashboard Cite

Platelets play an important role in hemostasis, and a low platelet count usually increases the risk of bleeding. Conditions in which thrombosis occurs despite low platelet counts are referred to as thrombosis with thrombocytopenia syndrome, including heparin-induced thrombocytopenia, vaccine-induced immune thrombotic thrombocytopenia, paroxysmal nocturnal hemoglobinuria, antiphospholipid syndrome, thrombotic microangiopathy (TMA), and disseminated intravascular coagulation. TMA includes thrombotic thrombocytopenic purpura, Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome (HUS), and atypical HUS. Patients with these pathologies present with thrombosis and consumptive thrombocytopenia associated with the activation of platelets and the coagulation system. Treatment varies from disease to disease, and many diseases have direct impacts on mortality and organ prognosis if therapeutic interventions are not promptly implemented. Underlying diseases and the results of physical examinations and general laboratory tests as part of a thorough workup for patients should promptly lead to therapeutic intervention before definitive diagnosis. For some diseases, the diagnosis and initial treatment must proceed in parallel. Utilization of not only laboratory tests but also various scoring systems is important for validating therapeutic interventions based on clinical information.

show abstract

Section: Stec-husmentioning

confidence: 99%